Feasibility of Telephone-based Acceptance and Commitment Therapy in Hong Kong Chinese Young Adults With Alcohol Use Disorder: A Pilot Study

March 26, 2026 updated by: Dr Eva Ho, The Hong Kong Polytechnic University

Objective: The proposed study aims to develop a protocol of telephone-based Acceptance and Commitment Therapy (ACT) for Alcohol Use Disorder (AUD) and examine the feasibility of implementing such intervention among the Hong Kong Chinese young adults with AUD.

Study design: A randomized controlled trial will be carried out. A convenience sample of 60 young adults with AUD will be recruited from the community. Subjects who are randomized into the experimental group which will receive a total of 6 weekly telephone-based ACT provided by an experienced health counsellor, or into the control group which will receive social support provided by a research assistant, that mimics the time and attention of the intervention. Feasibility measures will be collected at baseline (T0), 3- (T1) and 6- (T2) and 12-month (T3) follow-ups. Also, all subjects will be asked to complete a structured questionnaire to assess their alcohol use behaviours and psychological flexibility at the same time points.

Main outcome measures: The primary outcomes are feasibility measures by descriptive statistics. The secondary outcome is the preliminary effectiveness of telephone-based ACT in alcohol abstinence at 6 months

Data analysis: Multiple logistic regression will be used for analysis. Intention-to-treat analysis will be applied. Multiple imputations will be used to handle the missing data.

Study Overview

Status

Active, not recruiting

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Kowloon, Hong Kong
        • The Hong Kong Polytechnic University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • (1) aged 18 to 25 years,
  • (2) able to read Chinese and speak Cantonese
  • (3) drinking at hazardous levels as measured by the Alcohol Use Disorders Identification Test (AUDIT; score of ≥8)

Exclusion Criteria:

  • (1) those receiving other behavioural therapy for Alcohol Use Disorder (AUD)
  • (2) having a diagnosis of a psychiatric disorder

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: ACT
Telephone-based Acceptance and Commitment Therapy (ACT) for young adults with Alcohol Use Disorder (AUD)
Participants in the experimental group will receive a total of 6 weekly telephone-based Acceptance and Commitment Therapy (ACT) sessions.
Placebo Comparator: Control
Telephone-based social support
Participants in the control group will receive telephone-based social support weekly for 6 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Screening rate
Time Frame: Baseline
It will calculate the number of young adults screened by the research assistant divided by the number of young adults available for screening during the recruitment period.
Baseline
Eligibility rate
Time Frame: Baseline
It will be calculated as the number of eligible young adults divided by the number of screened young adults.
Baseline
Consent rate
Time Frame: Baseline
It will be calculated as the number of eligible young adults who join the study divided by the number of eligible young adults.
Baseline
Randomization rate
Time Frame: Baseline
It will be calculated as the number of young adults who are randomized into the experimental and control groups, divided by the number of eligible young adults who consent to join the study.
Baseline
Attendance rate to the intervention
Time Frame: at baseline (T0), 3- (T1) and 6- (T2) and 12-month (T3) follow-ups
It will be calculated as the number of subjects in the experimental group who complete the intervention divided by the number of subjects randomized into the experimental group.
at baseline (T0), 3- (T1) and 6- (T2) and 12-month (T3) follow-ups
Adherence to intervention
Time Frame: at baseline (T0), 3- (T1) and 6- (T2) and 12-month (T3) follow-ups
It will be calculated as the number of subjects in the experimental group who practice the ACT skills gained in the intervention divided by the number of subjects randomized into the experimental group. It will be calculated at each follow-up.
at baseline (T0), 3- (T1) and 6- (T2) and 12-month (T3) follow-ups
Retention rate
Time Frame: at baseline (T0), 3- (T1) and 6- (T2) and 12-month (T3) follow-ups
It will be calculated the number of subjects who remain in the study, divided by the number of subjects who are randomized. It will be calculated by groups at each follow-up.
at baseline (T0), 3- (T1) and 6- (T2) and 12-month (T3) follow-ups
Completion rate
Time Frame: at baseline (T0), 3- (T1) and 6- (T2) and 12-month (T3) follow-ups
It is calculated as the number of subjects who answer the questionnaires divided by the number of questionnaires distributed.
at baseline (T0), 3- (T1) and 6- (T2) and 12-month (T3) follow-ups
Missing data
Time Frame: at baseline (T0), 3- (T1) and 6- (T2) and 12-month (T3) follow-ups
It is defined as the percentage of missing in the dataset. Unknown or blank values will be regarded as missing.
at baseline (T0), 3- (T1) and 6- (T2) and 12-month (T3) follow-ups
Adverse event
Time Frame: at baseline (T0), 3- (T1) and 6- (T2) and 12-month (T3) follow-ups
unfavorable and unintended events.
at baseline (T0), 3- (T1) and 6- (T2) and 12-month (T3) follow-ups

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Weekly alcohol consumption
Time Frame: at 6-month (T2) follow-ups
Drinks per week over the past 30 days. The Timeline Follow-Back questionnaire (TLFB) will be used to determine the number of alcohol-free days from drinking days, and the number of drinks consumed per day.
at 6-month (T2) follow-ups
Psychological flexibility
Time Frame: at 6-month (T2) follow-ups
The Acceptance and Action Questionnaire II (AAQII) will be used to measure psychological flexibility. This questionnaire contains 7 items, with each rated on a 7-point scale, from 1 (never true) to 7 (always true). Lower scores indicate greater levels of psychological flexibility.
at 6-month (T2) follow-ups

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2023

Primary Completion (Estimated)

April 1, 2027

Study Completion (Estimated)

April 1, 2027

Study Registration Dates

First Submitted

March 17, 2026

First Submitted That Met QC Criteria

March 26, 2026

First Posted (Actual)

March 30, 2026

Study Record Updates

Last Update Posted (Actual)

March 30, 2026

Last Update Submitted That Met QC Criteria

March 26, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Alcohol Use Disorder

Clinical Trials on ACT

Subscribe